CRP and colorectal carcinoma: Inflammation has been widely recognized as a factor that contributes to cancer progression, and many inflammatory markers, such as C-reactive protein (CRP), the Glasgow Prognostic Score (GPS), and the modified GPS (mGPS), have been shown to be associated with survival in CRC patients (Nasr et al., 2018; Matsubara et al., 2020).